The SHINE-MDT Randomized Controlled Trial

NACompletedINTERVENTIONAL
Enrollment

233

Participants

Timeline

Start Date

April 27, 2023

Primary Completion Date

December 1, 2023

Study Completion Date

June 1, 2024

Conditions
Head and Neck CarcinomaRadiotherapy Side Effects
Interventions
BEHAVIORAL

Whole-Course Multidisciplinary Care Intervention

On the basis of standard treatment, all patients were evaluated by senior practice nurses in the Department of Oncology in person at the time of enrollment (before radiotherapy) and once every week during radiotherapy, and once in person/over the phone at 1, 2, 3, and 6 months after radiotherapy.

Trial Locations (1)

610041

West China Hospital, Sichuan University, Chengdu

All Listed Sponsors
lead

West China Hospital

OTHER

NCT05828004 - The SHINE-MDT Randomized Controlled Trial | Biotech Hunter | Biotech Hunter